Neuren Pharmaceuticals Ltd (NEU) — Capital Reinvestment Ratio
Latest as of June 2025:
0.00x
Neuren Pharmaceuticals Ltd (NEU) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$128.31 Million) in capital expenditures (AU$5.00K). See NEU FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
AU$128.31 Million
AUD
Capital Expenditures
AU$5.00K
AUD
Data as of
Jun 2025
Most recent filing
Neuren Pharmaceuticals Ltd Capital Reinvestment Ratio (2018–2023)
This chart tracks Neuren Pharmaceuticals Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Neuren Pharmaceuticals Ltd (2018–2023)
Year-by-year Capital Reinvestment Ratio for Neuren Pharmaceuticals Ltd from 2018 to 2023. For live market cap and broader valuation context, see Neuren Pharmaceuticals Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.00x | AU$184.93 Million | AU$40.00K | ▼ -95.9% |
| 2022 | 0.01x | AU$3.60 Million | AU$19.00K | ▲ +181.9% |
| 2018 | 0.00x | AU$6.41 Million | AU$12.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow